ALIGN TECHNOLOGY INC (ALGN)

Align Technology, Inc. is a global medical device company headquartered in Tempe, Arizona, that designs, manufactures, and markets Invisalign clear aligners for treating malocclusions, Vivera retainers, iTero intraoral scanners, and exocad CAD/CAM software for dental laboratories and practitioners. The company operates through two segments: Clear Aligner (approximately 80% of 2025 net revenues) and Systems and Services (approximately 20%), serving customers globally through a direct sales force, sales agents, distributors, dental support organizations, and dental laboratories, with regional headquarters in Raleigh, North Carolina; Rotkreuz, Switzerland; and Singapore. Align's strategy centers on the Align Digital Platform, an integrated, end-to-end suite of proprietary technologies spanning the treatment journey—Connect, Scan, Diagnose, Plan, Treat, Monitor, and Retain—designed to unify doctors, labs, patients, and consumers in a seamless digital workflow.

Since receiving FDA 510(k) clearance in 1998, the Invisalign System has treated over 22 million patients using custom, computer-simulated ClinCheck treatment plans and doctor-prescribed, sequentially worn clear aligners manufactured via proprietary technologies including SmartTrack material, SmartForce attachments, and SmartStage algorithms; the product line spans Comprehensive packages (including Invisalign First for younger patients and the new Invisalign System with mandibular advancement featuring occlusal blocks for Class II correction) and Non-Comprehensive packages (Express, Lite, Moderate, Go, and the Doctor Subscription Program), along with the FDA-cleared Invisalign Palatal Expander System and Vivera retainers. Align's Systems and Services segment centers on the iTero Element and iTero Lumina intraoral scanner portfolios—featuring technologies like NIRI caries detection, TimeLapse comparison, and the newly enhanced iTero Digital Solutions ecosystem (including the Align Oral Health Suite, Outcome Simulator Pro, and iTero Design Suite)—which integrate with exocad CAD/CAM software to support both orthodontic and restorative digital workflows. The company estimates roughly 600 million people globally suffer from malocclusion, with about 22 million annual case starts through orthodontists, of which Align captures approximately 10% share, representing significant growth opportunity.

Recent innovation milestones in 2025 include restorative-capable iTero Lumina and Lumina Pro scanners, the AI-driven Align X-Ray Insights tool launched in the EU and UK, expanded iTero Digital Solutions capabilities, and limited commercial availability of the mandibular advancement aligner system; the company also completed the acquisition of Cubicure GmbH in January 2024 to advance proprietary direct 3D printing manufacturing capabilities aimed at scaling production and reducing material use across its product portfolio.